Exact Mass: 715.3792238

Exact Mass Matches: 715.3792238

Found 55 metabolites which its exact mass value is equals to given mass value 715.3792238, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Saquinavir-NO

N-{4-[3-(tert-butyl-C-hydroxycarbonimidoyl)-decahydroisoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-[(quinolin-2-yl)formamido]butanediimidate

C38H49N7O7 (715.3693284000001)

Amamistatin B

C36H53N5O10 (715.3792238)

(+)-Maackinine

C39H57NO11 (715.3931412)

Nummularine O

N-Desmethyljubanine B

C42H45N5O6 (715.336967)

3-Acetyl-15-veratroylgermine

C38H53NO12 (715.3567578)

Exumolide B

C40H53N5O7 (715.3944787999999)

9alpha,13alpha-diacetoxy-10beta-benzyloxy-5alpha-(3-dimethylamino-3-phenyl)-propionyloxy-11(15->1)abeotaxa-4(20),11-diene-15-ol

C42H53NO9 (715.3720128)

FQFFK

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693284000001)

erbium tris(2,2,6,6-tetramethyl-3,5-heptanedionate)

C33H57ErO6 (715.3457972000001)

Boc-Gln-Arg-Arg-AMC

C32H49N11O8 (715.3765394000001)

H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt

C28H49N11O11 (715.3612844)

GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). GRGDSPK (EMD 56574) is an competitive and reversible inhibitory peptide for inhibiting integrin-fibronectin binding. GRGDSPK is used to study the role of integrins in bone formation and resorption[1][2].

2-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin

C28H57N7O14 (715.3963302)

N-{4-[3-(tert-butylcarbamoyl)-octahydro-1H-isoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-(quinolin-2-ylformamido)succinamide

C38H49N7O7 (715.3693284000001)

(7Z,10Z,13Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]hexadeca-7,10,13-trienamide

C36H61NO13 (715.4142696)

(4Z,7Z,10Z,13Z)-N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]hexadeca-4,7,10,13-tetraenamide

C36H61NO13 (715.4142696)

(2S)-2-amino-3-[2,3-bis[[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy]propoxy-hydroxyphosphoryl]oxypropanoic acid

C38H54NO10P (715.3485154)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H62NO8P (715.4212822)

[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H62NO8P (715.4212822)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

C40H62NO8P (715.4212822)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

C40H62NO8P (715.4212822)

neocasomorphin(1-)

C35H51N6O10 (715.3666486000001)

A peptide anion obtained from the deprotonation of the two carboxy groups, and protonation of the primary amino group of neocasomorphin. It is the major species at pH 7.3.